Pancreatic Cancer Europe is a legal entity (ASBL) since 2016 registered in Brussels - Belgium, under the number ASBL n°656.553.804. All decisions regarding the platform are taken collectively by platform members, each of them having an equal voice in the decisions regarding the platform’s activities and orientations.
Our administration board:
Professor of Medical Oncology at Alcala University and Director of the Medical Oncology Department at Ramon y Cajal University Hospital in Madrid, Spain. He is presently serving as Director of the Ramon y Cajal Institute for Health Research IRYCIS.
Professor of Medicine and senior physician at Karolinska Institutet (Stockholm, Sweden) Department of Clinical Science, Intervention and Technology, Prof. Löhr is one of the leading European pancreatic cancer experts, as well as UEG (United European Gastroenterology) spokesperson.
Diagnosed in 2007, Ali Stunt is one of the few pancreatic cancer surviving patients. Saved by an early diagnosis of the disease, Ali is the Founder and Chief Executive of Pancreatic Cancer Action (UK), an association devoted to encourage early diagnosis for the illness.
Director of the European Cancer Patient Coalition (ECPC)
Dr. Núria Malats
Head of the Genetic and Molecular Epidemiology Group at the Spanish National Cancer Research Centre (CNIO), Madrid, Spain.